tiprankstipranks
Haemonetics Corp. (HAE)
NYSE:HAE
US Market

Haemonetics (HAE) Financial Statements

Compare
397 Followers

Haemonetics Financial Overview

Haemonetics's market cap is currently $3.19B. The company's EPS TTM is $2.541; its P/E ratio is 24.97; Haemonetics is scheduled to report earnings on February 6, 2025, and the estimated EPS forecast is $1.22. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Jun 23Jun 22Jun 21Mar 20
Income Statement
Total Revenue$ 1.31B$ 1.17B$ 993.20M$ 870.46M$ 988.48M
Gross Profit$ 691.55M$ 615.10M$ 505.50M$ 397.84M$ 484.51M
Operating Income$ 164.88M$ 156.03M$ 80.75M$ 57.96M$ 153.95M
EBITDA$ 265.58M$ 249.34M$ 178.50M$ 142.25M$ 264.24M
Net Income$ 117.56M$ 115.40M$ 43.38M$ 79.47M$ 76.53M
Balance Sheet
Cash & Short-Term Investments$ 178.80M$ 284.47M$ 259.50M$ 192.31M$ 137.31M
Total Assets$ 2.20B$ 1.93B$ 1.86B$ 1.82B$ 1.27B
Total Debt$ 807.79M$ 765.89M$ 773.59M$ 707.61M$ 382.49M
Net Debt$ 628.99M$ 481.42M$ 514.09M$ 515.30M$ 245.18M
Total Liabilities$ 1.24B$ 1.12B$ 1.11B$ 1.09B$ 680.00M
Stockholders' Equity$ 959.96M$ 818.00M$ 749.42M$ 731.67M$ 587.11M
Cash Flow
Free Cash Flow$ 115.45M$ 162.87M$ 75.75M$ 71.77M$ 109.46M
Operating Cash Flow$ 181.75M$ 273.06M$ 172.26M$ 108.81M$ 158.22M
Investing Cash Flow$ -322.39M$ -143.79M$ -86.34M$ -425.44M$ -57.18M
Financing Cash Flow$ 38.16M$ -100.36M$ -15.75M$ 367.45M$ -131.21M
Currency in USD

Haemonetics Earnings and Revenue History

Haemonetics Debt to Assets

Haemonetics Cash Flow

Haemonetics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis